Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Regulatory Services (NRS) is a prominent compliance consulting and technology firm that provides regulatory solutions primarily for the financial services industry, including investment advisers, broker-dealers, and hedge funds. Founded in 1984, the company offers a comprehensive suite of services such as regulatory filings, compliance reviews, and the ComplianceGuardian™ software platform. While its core business is financial compliance, NRS is also active in the life sciences and healthcare sectors through its regulatory intelligence services, frequently engaging with the FDA to obtain inspection reports (Form 483s) and other regulatory data for industry analysis. In October 2021, NRS was acquired by ComplySci (now COMPLY) to integrate its expert consulting and educational programs into a broader regulatory technology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Regulatory Services.